Scripps Memorial Hospital
La Jolla, California 92307
5 studies enrolling now · 35 studies all time
What they study most
Acute Decompensated Heart Failure, Aortic Stenosis, Aortic Valve Replacement, Aortic Valve Stenosis, Atrial Fibrillation, Bleeding, Calcific Aortic Stenosis, Cardiac Disease, Cardiomyopathy, Hypertrophic, Cardiovascular Disease, Cardiovascular Diseases, Carotid Artery Disease
Studies at this site
- Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure — Recruiting now
- AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions — Recruiting now
- Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360) — Recruiting now
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Recruiting now
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Running, not enrolling
- CHAMPION-AF Clinical Trial — Running, not enrolling
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
- SIMPLAAFY Clinical Trial — Running, not enrolling
- Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
- SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial — Running, not enrolling
- Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System — Completed
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
- ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study — Completed
- HEAL-LAA Clinical Trial — Completed
- Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
- LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study — Completed
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk — Completed
- ABSORB III Randomized Controlled Trial (RCT) — Completed
- MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram — Status unconfirmed
- Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial — Completed
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve — Completed
- ACT34-CMI -- Adult Autologous CD34+ Cells — Completed
- Trevo® Retriever Registry Post Market Surveillance — Completed
- Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 — Stopped early
- The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B — Completed
- The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) — Completed
- Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158 — Completed
- TAXUS PERSEUS Workhorse — Completed
- SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System — Completed
- Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries — Completed
- SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) — Completed
- Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts — Completed
- RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System — Completed
- Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102) — Completed